Dr. Michael “Dr. T” Tokiwa is a practicing small-animal veterinarian, hospital owner, mentor, and advisor who believes great medicine starts with trust—and grows through collaboration. Dr. Michael “Dr ...

Grapiprant (Galliprant) is a nonsteroidal anti-inflammatory drug (NSAID) your veterinarian might give your dog to help treat their osteoarthritis pain. Grapiprant is FDA-approved for short- or ...

Question: I have an old mixed-breed dog that has had arthritis for years and it has gotten to the point where he needs my help to get up off the floor. It is getting very hard for me to lift him. He ...

Eli Lilly and Company’s LLY animal health subsidiary, Elanco and partner Aratana Therapeutics, Inc. PETX together announced the availability of a new drug - Galliprant (grapiprant tablets) to the ...

Galliprant was proven effective in a placebo-controlled, 16-site field study evaluating 285 dogs with OA. 4 Both veterinary and owner assessments reported statistically significant improvement in pain ...

Aratana Therapeutics Inc. recently filed an application with the European Medicines Agency to get approval for the pet drug Galliprant. Just a few weeks after Aratana Therapeutics Inc. filed an ...

LEAWOOD, Kan., Nov. 10, 2017 /PRNewswire/ -- Elanco Animal Health, a division of Eli Lilly and Company (NYSE: LLY) and Aratana Therapeutics, Inc. (NASDAQ: PETX), today announced the European Medicine ...

LEAWOOD, Kan., Jan. 25, 2016 /PRNewswire/ -- Aratana Therapeutics, Inc. (NASDAQ: PETX), a pet therapeutics company focused on the licensing, development and commercialization of innovative ...

Shares of Aratana Therapeutics ($PETX) jumped 25% to $3.99 a share in after-market trading on January 25, after the company announced it had filed for FDA approval of ...

LEAWOOD, Kan., April 26, 2019 /PRNewswire/ -- Aratana Therapeutics (NASDAQ: PETX), a pet therapeutics company focused on developing and commercializing innovative therapeutics for dogs and cats, ...